Skip to main content
INMD
NASDAQ Industrial Applications And Services

InMode Q2 Earnings Flat as Margins Compress; Full-Year Guidance Issued Amid Takeover Battle

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$15.37
Mkt Cap
$883.479M
52W Low
$12.72
52W High
$16.74
52W Position info
21% above low
Off High info
8.2% below high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

INMD sits 21% above its 52-week low of $12.72.

Summary

InMode reported flat Q2 revenue of $95.6M but saw margins compress sharply, with GAAP operating income down 46% YoY. The company provided full-year 2026 guidance for the first time and disclosed it will not host a conference call due to the ongoing evaluation of take-private proposals.


Key Events · Earnings and Guidance · INMD

  • Revenue Flat, Margins Compress

    Q2 GAAP revenue of $95.6M was consistent with Q2 2025, but GAAP operating margin fell to 13% from 24% a year ago, driven by higher COGS, sales restructuring, and increased G&A expenses.

  • Earnings Decline Sharply

    GAAP net income dropped to $17.1M ($0.29 per diluted share) from $26.7M ($0.42) a year ago. Non-GAAP net income fell to $20.8M ($0.35) from $30.1M ($0.47).

  • Full-Year 2026 Guidance Issued

    Management expects full-year revenue of $365M–$375M, non-GAAP gross margin of 74%–76%, non-GAAP operating income of $68M–$73M, and non-GAAP EPS of $1.29–$1.34.

  • Share Repurchase Completed

    The company completed the repurchase of 6.38 million ordinary shares for $87.8 million under its previously announced program.


Analysis · INMD · Industrial Applications And Services

InMode's Q2 revenue was flat year-over-year at $95.6 million, but profitability took a significant hit — GAAP operating margin fell to 13% from 24% a year ago, driven by higher costs, sales restructuring, and increased professional fees. The company issued full-year 2026 guidance for the first time, projecting revenue of $365–$375 million and non-GAAP EPS of $1.29–$1.34, which implies a continued margin squeeze. The results land in the middle of a heated takeover contest, with the board's special committee still evaluating competing bids from the CEO-led group and Steel Partners. The decision to skip the earnings call underscores the distraction and uncertainty surrounding the company's future.

At the time of this filing, INMD was trading at $15.37 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $883.5M. The 52-week trading range was $12.72 to $16.74. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

INMD - Latest Insights

INMD
Aug 05, 2026, 7:00 AM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $15.37
Real-time Price: $15.37 info
Change: $0 (0%) info
Market Cap: $883.479M info
INMD
Jul 20, 2026, 4:01 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $15.36
Real-time Price: $15.37 info
Change: +$0.0100 (+0.07%) info
Market Cap: $883.479M info
INMD
Jul 20, 2026, 7:21 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $15.31
Real-time Price: $15.37 info
Change: +$0.060 (+0.39%) info
Market Cap: $883.479M info
INMD
Jul 16, 2026, 5:51 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $15.50
Real-time Price: $15.37 info
Change: -$0.130 (-0.84%) info
Market Cap: $883.479M info
INMD
Jul 13, 2026, 9:00 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $15.20
Real-time Price: $15.37 info
Change: +$0.170 (+1%) info
Market Cap: $883.479M info